CDG Invest Growth has officially acquired a stake in Dislog Dispositifs Médicaux (DDM), the medical device subsidiary of Dislog Group. The transaction, carried out through the Capmezzanine III fund in partnership with Mediterrania Capital Partners, was finalized via a reserved capital increase. The investment marks a key milestone in DDM’s growth trajectory and is intended to support the company’s strategic expansion—particularly through a wave of acquisitions launched in recent months.
With this financial backing, DDM aims to solidify its presence in Morocco’s medical device sector and lay the groundwork to become a leading regional player. Formed in March 2025, DDM has quickly brought together four specialized companies—Afrobiomedic, Eramedic, Farmalac, and Megaflex. Each operates in distinct but complementary areas, including laboratory equipment, cardiology, gastroenterology, and pharmaceutical packaging. This diverse portfolio allows DDM to cover a broad range of needs in the healthcare supply chain.
For CDG Invest Growth, a prominent name in Moroccan private equity, this marks its fifth investment in the healthcare sector. The firm has a long-standing track record of helping companies structure their operations and scale strategically, often through active participation in corporate governance and targeted expansion plans.
The deal represents the largest capital raise in Dislog Group’s history and reflects a broader strategy of long-term value creation. By aligning complementary businesses under one umbrella, the group is positioning itself to not only strengthen its market share but also play a pivotal role in shaping the regional health industry landscape.
